Safety and efficacy of vismodegib and impact of treatment breaks in advanced basal cell carcinoma: Interim analysis of the STEVIE study in 499 patients

被引：0
|
作者：
Kuntsfeld, Rainer [1 ]
Grob, Jean-Jacques [2 ]
Mortier, Laurent [3 ]
Ascierto, Paolo Antonio [4 ]
Guillot, Bernard [5 ]
Williams, Sarah [6 ]
Xynos, Ioannis [6 ]
Basset-Seguin, Nicole [7 ]
Hansson, Johan [8 ]
Hauschild, Axel [9 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Timone Hosp, Marseille, France
[3] Univ Lille 2, Lille, France
[4] Ist Nazl Tumori Fondaz G Pascale, Naples, Italy
[5] Univ Hosp Montpellier, Montpellier, France
[6] Roche Prod Ltd, Welwyn Garden City, Herts, England
[7] Univ Paris 07, Paris, France
[8] Karolinska Inst, Stockholm, Sweden
[9] Univ Hosp Schleswig Holstein, Kiel, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
3122
引用
收藏
页码：AB204 / AB204
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
    Anne Lynn S. Chang
    Sarah T. Arron
    Michael R. Migden
    James A. Solomon
    Simon Yoo
    Bann-Mo Day
    Edward F. McKenna
    Aleksandar Sekulic
    Orphanet Journal of Rare Diseases, 11
  • [32] Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
    Chang, Anne Lynn S.
    Arron, Sarah T.
    Migden, Michael R.
    Solomon, James A.
    Yoo, Simon
    Day, Bann-Mo
    McKenna, Edward F.
    Sekulic, Aleksandar
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [33] The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma
    Lacouture, M.
    Guillen, J.
    Kudchadkar, R.
    Rogers, G.
    Olencki, T.
    Tang, J. Y.
    Yoo, S.
    Dawson, K.
    Mun, Y.
    Sekulic, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S679 - S680
  • [34] Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
    Sekulic, Aleksandar
    Migden, Michael R.
    Basset-Seguin, Nicole
    Garbe, Claus
    Gesierich, Anja
    Lao, Christopher D.
    Miller, Chris
    Mortier, Laurent
    Murrell, Dedee F.
    Hamid, Omid
    Quevedo, Jorge F.
    Hou, Jeannie
    McKenna, Edward
    Dimier, Natalie
    Williams, Sarah
    Schadendorf, Dirk
    Hauschild, Axel
    BMC CANCER, 2017, 17
  • [35] Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
    Alessia Villani
    Gabriella Fabbrocini
    Claudia Costa
    Massimiliano Scalvenzi
    Dermatology and Therapy, 2020, 10 : 401 - 412
  • [36] Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
    Villani, Alessia
    Fabbrocini, Gabriella
    Costa, Claudia
    Scalvenzi, Massimiliano
    DERMATOLOGY AND THERAPY, 2020, 10 (03) : 401 - 412
  • [37] Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
    Aleksandar Sekulic
    Michael R. Migden
    Nicole Basset-Seguin
    Claus Garbe
    Anja Gesierich
    Christopher D. Lao
    Chris Miller
    Laurent Mortier
    Dedee F. Murrell
    Omid Hamid
    Jorge F. Quevedo
    Jeannie Hou
    Edward McKenna
    Natalie Dimier
    Sarah Williams
    Dirk Schadendorf
    Axel Hauschild
    BMC Cancer, 17
  • [38] Efficacy and safety profile of vismodegib in a real-world setting cohort of patients with advanced basal cell carcinoma in Argentina
    Cozzani, Romina
    del Aguila, Roxana
    Carrizo, Mariano
    Sanchez, Sergio
    Gonzalez, Abel
    Chiacchietta, A.
    Alonso, C.
    Ferrandini, S.
    Molinari, L.
    Fontana
    Murineddu, E. Ruiz
    Del Aguila, R.
    Perelli, L.
    Dupertuis, M.
    Valentini, J.
    Alfaro, R. Diaz
    Mazzuoccolo, L.
    Pelati, M.
    Costa, L.
    Rodriguez, S.
    Ferrario, D.
    Iturbe, J.
    Roy, R. Mendez
    Bozzano, A.
    Romero, A.
    Paez, J. C.
    Berra, A. Colombo
    Streich, G.
    Prisco, Aguilera
    Gonzalez, A.
    Caceres, H.
    Sosa, A.
    Pascale, M.
    Hunis, A.
    Latorre, K.
    Piazzoni, L.
    Di Noto, Lopez
    Oliva, M. E.
    Melamed, M.
    Arrozpide, L.
    Daverede, L.
    Ayala, N.
    Koller, V. Martin
    Vicente, D.
    Maskin, Matias
    Abeldano, A.
    Garbaos, G.
    Palma, G.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (05) : 627 - 632
  • [39] Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study
    Bossi, Paolo
    Peris, Ketty
    Calzavara-Pinton, Piergiacomo
    Queirolo, Paola
    Alfieri, Salvatore
    Palla, Marco
    Rossi, Maria Teresa
    Spagnolo, Francesco
    Tambone, Sara
    Astolfi, Cinzia
    Ascierto, Paolo A.
    FUTURE ONCOLOGY, 2020, 16 (16) : 1091 - 1100
  • [40] Vismodegib approved by US FDA for the treatment of advanced basal cell carcinoma
    Attwood, Claire
    FUTURE ONCOLOGY, 2012, 8 (03) : 227 - 227
12345